A Phase II, Multicentre Trial Evaluating the Efficacy of De-Escalated Bisphosphonate Therapy in Metastatic Breast Cancer Patients at Low-Risk of Skeletal-Related Events
Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-014-2906-x
Full Text
Open PDFAbstract
Available in full text
Date
March 18, 2014
Authors
Publisher
Springer Science and Business Media LLC